Robert V. Baumgartner - Oct 30, 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for Robert V. Baumgartner pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Oct 30, 2025
Transactions value $
$0
Form type
4
Date filed
11/3/2025, 05:22 PM
Previous filing
Aug 27, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BAUMGARTNER ROBERT V Director 614 MCKINLEY PL NE, MINNEAPOLIS /s/ Andrew Nick as Attorney-in-Fact for Robert V. Baumgartner pursuant to Power of Attorney previously filed. 2025-11-03 0001258704

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Award $0 +1.64K +3.66% $0.00 46.5K Oct 30, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Award $0 +3.78K $0.00 3.78K Oct 30, 2025 Common Stock 3.78K $60.96 Direct F1
holding TECH Stock Options (Right to Buy) 15.9K Oct 30, 2025 Common Stock 15.9K $25.30 Direct
holding TECH Stock Options (Right to Buy) 12.5K Oct 30, 2025 Common Stock 12.5K $31.26 Direct
holding TECH Stock Options (Right to Buy) 7.59K Oct 30, 2025 Common Stock 7.59K $44.96 Direct
holding TECH Stock Options (Right to Buy) 8.04K Oct 30, 2025 Common Stock 8.04K $50.41 Direct
holding TECH Stock Options (Right to Buy) 6.03K Oct 30, 2025 Common Stock 6.03K $63.92 Direct
holding TECH Stock Options (Right to Buy) 2.53K Oct 30, 2025 Common Stock 2.53K $128.81 Direct
holding TECH Stock Options (Right to Buy) 3.46K Oct 30, 2025 Common Stock 3.46K $73.94 Direct
holding TECH Stock Options (Right to Buy) 3.94K Oct 30, 2025 Common Stock 3.94K $61.51 Direct
holding TECH Stock Options (Right to Buy) 3.51K Oct 30, 2025 Common Stock 3.51K $68.37 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.